US03837C1062 - Common Stock
APYX stock results show that Apyx Medical missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Apyx Medical (NASDAQ:APYX) just reported results for the fourth quarter of 2023...
Apyx Medical (APYX) stock rose after the company announced publication a safety analysis in a peer-reviewed journal for its product Reunvion following liposuction. Read more here.
Apyx Medical's CFO, Matthew Hill, purchased 2.5K common shares at $2.19/share, as company shares rose 3.8% on Thursday.
Apyx Medical appoints Matthew Hill as CFO, replacing Tara Semb.
Apyx Medical CEO Charles Goodwin purchases 50K shares at $1.57 each, boosting his total holding to 90K shares.
Apyx Medical enters into a 5-year credit agreement with Perceptive Credit Holdings, securing $37.5M initial loan to fulfill obligations and expenses.